Literature DB >> 15674021

A multiwell assay to isolate compounds inhibiting the assembly of the prokaryotic RNA polymerase.

Estelle André1, Lionel Bastide, Philippe Villain-Guillot, Jaqueline Latouche, Joelle Rouby, Jean-Paul Leonetti.   

Abstract

We have developed a multiwell assay for the detection of modulators of prokaryotic transcription based on the quantification of protein-protein interaction. This assay consists of three steps: (a) the immobilization of the Escherichia coli protein sigma70 in the well, (b) the incubation of the immobilized protein with core RNA polymerase and a potential inhibitor, and (c) washing and quantification of the binding of core to sigma70 with a monoclonal antibody conjugated to horseradish peroxidase. We show that this assay is sensitive, reproducible, and robust, and is able to discriminate between control competitors with different affinities. We demonstrate the usefulness of the assay to screen for microbial RNA polymerase inhibitors as potential new drugs for the treatment of emerging antibiotic-resistant bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15674021     DOI: 10.1089/adt.2004.2.629

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  8 in total

1.  Influence of DNA template choice on transcription and inhibition of Escherichia coli RNA polymerase.

Authors:  Joerg Haupenthal; Kristina Hüsecken; Matthias Negri; Christine K Maurer; Rolf W Hartmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  Bacterial Transcription as a Target for Antibacterial Drug Development.

Authors:  Cong Ma; Xiao Yang; Peter J Lewis
Journal:  Microbiol Mol Biol Rev       Date:  2016-01-13       Impact factor: 11.056

3.  The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.

Authors:  Virginie Vives; Mélanie Laurin; Gaelle Cres; Pauline Larrousse; Zakia Morichaud; Danièle Noel; Jean-François Côté; Anne Blangy
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

4.  A screen to identify small molecule inhibitors of protein-protein interactions in mycobacteria.

Authors:  Deborah Mai; Jennifer Jones; John W Rodgers; John L Hartman; Olaf Kutsch; Adrie J C Steyn
Journal:  Assay Drug Dev Technol       Date:  2011-01-31       Impact factor: 1.738

Review 5.  Bacterial RNA Polymerase-DNA Interaction-The Driving Force of Gene Expression and the Target for Drug Action.

Authors:  Jookyung Lee; Sergei Borukhov
Journal:  Front Mol Biosci       Date:  2016-11-09

6.  First-In-Class Inhibitors Targeting the Interaction between Bacterial RNA Polymerase and Sigma Initiation Factor Affect the Viability and Toxin Release of Streptococcus pneumoniae.

Authors:  Jiqing Ye; Adrian Jun Chu; Lin Lin; Xiao Yang; Cong Ma
Journal:  Molecules       Date:  2019-08-09       Impact factor: 4.411

7.  Studying the salt dependence of the binding of sigma70 and sigma32 to core RNA polymerase using luminescence resonance energy transfer.

Authors:  Bryan T Glaser; Veit Bergendahl; Larry C Anthony; Brian Olson; Richard R Burgess
Journal:  PLoS One       Date:  2009-08-03       Impact factor: 3.240

8.  Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction.

Authors:  Jiqing Ye; Adrian Jun Chu; Lin Lin; Shu Ting Chan; Rachel Harper; Min Xiao; Irina Artsimovitch; Zhong Zuo; Cong Ma; Xiao Yang
Journal:  Eur J Med Chem       Date:  2020-08-18       Impact factor: 6.514

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.